Astal Laboratories Board Authorises Rs 300 Crore Fundraise And Acquisition Talks

Board authorized exploring acquisition of USFDA/EU-GMP/WHO-GMP compliant pharma manufacturing units to expand capacity. Also authorized discussions to raise up to Rs 300 Cr via CCDs/CCPS/NCDs through private placement, subject to approvals.